Commentary
News
The end of aspirin for primary prevention
News
Should toe amputation be delayed in diabetic patients with osteomyelitis?
Two vascular surgeons face off on the pros and cons.
Commentary
NIH director expresses concern over CRISPR-cas9 baby claim
“Lest there be any doubt, and as we have stated previously, NIH does not support the use of gene-editing technologies in human embryos.”
Opinion
Recognize gender expression in youth
Video
‘Phenomenal’ REDUCE-IT establishes triglyceride theory
Why did REDUCE-IT succeed while other trials and compounds failed? Dr. Deedwania explains that it, for the first time, used the appropriate...
Managing Your Practice
How well are your phones being answered?
Even now, in the era of texting and e-mail, the telephone remains our primary point of contact with new and long-time patients.
Commentary
Veterans are not ‘ticking time bombs’
Opinion
FDA approval of powerful opioid tinged with irony
The agency’s approval of Dsuvia comes at a time when the need is great for nonaddictive agents for pain control.
Med Tech Report
Where to go with wearables
First and foremost, providers need confidence in the accuracy of the monitoring equipment, and, thus far, that accuracy has been questionable.
Commentary
Tribute: Herb Kleber’s ‘generosity of spirit’ matched by few
Dr. Kleber “enabled the research careers of a whole new generation of leaders” in addiction medicine.
News
Heart cell transplant rejections
Piero Anversa’s fraudulent research led to an NIH study in humans that is still ongoing.